JLens 500 Jewish Advocacy U.S. ETF (NYSEARCA:TOV – Get Free Report) was the target of a large decrease in short interest in December. As of December 31st, there was short interest totaling 961 shares, a decrease of 96.9% from the December 15th total of 31,393 shares. Based on an average daily trading volume, of 31,257 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are sold short. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 31,257 shares, the short-interest ratio is presently 0.0 days.
JLens 500 Jewish Advocacy U.S. ETF Stock Up 0.1%
NYSEARCA:TOV traded up $0.03 on Monday, reaching $29.26. 9,864 shares of the company’s stock traded hands, compared to its average volume of 9,138. The stock has a 50-day simple moving average of $28.66 and a 200-day simple moving average of $27.79. JLens 500 Jewish Advocacy U.S. ETF has a 12 month low of $20.40 and a 12 month high of $29.92. The firm has a market cap of $210.09 million, a PE ratio of 25.69 and a beta of 1.00.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in JLens 500 Jewish Advocacy U.S. ETF stock. Captrust Financial Advisors purchased a new position in JLens 500 Jewish Advocacy U.S. ETF (NYSEARCA:TOV – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 231,726 shares of the company’s stock, valued at approximately $6,038,000. Captrust Financial Advisors owned 3.60% of JLens 500 Jewish Advocacy U.S. ETF at the end of the most recent reporting period.
JLens 500 Jewish Advocacy U.S. ETF Company Profile
The JLens 500 Jewish Advocacy U.S. ETF (TOV) is an exchange-traded fund that is based on the JLens 500 Jewish Advocacy U.S. index. The fund tracks an index of large-cap US stocks while employing a methodology that seeks to align stock selection and weighting with Jewish value pillars. TOV was launched on Feb 26, 2025 and is issued by JLens.
See Also
- Five stocks we like better than JLens 500 Jewish Advocacy U.S. ETF
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Gold Breakout ALERT
- Trump’s Hand-Written Letter Will Shock his Haters
Receive News & Ratings for JLens 500 Jewish Advocacy U.S. ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JLens 500 Jewish Advocacy U.S. ETF and related companies with MarketBeat.com's FREE daily email newsletter.
